Next Article in Journal
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells
Previous Article in Journal
Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer
Previous Article in Special Issue
Activity-Based Probes for Proteases Pave the Way to Theranostic Applications
 
 
Editorial

Article Versions Notes

Pharmaceutics 2022, 14(7), 1516; https://doi.org/10.3390/pharmaceutics14071516
Action Date Notes Link
article xml file uploaded 21 July 2022 13:59 CEST Original file -
article xml uploaded. 21 July 2022 13:59 CEST Update -
article pdf uploaded. 21 July 2022 13:59 CEST Version of Record -
article html file updated 21 July 2022 14:00 CEST Original file -
article html file updated 21 July 2022 14:00 CEST Update -
article xml file uploaded 21 July 2022 14:01 CEST Update -
article xml uploaded. 21 July 2022 14:01 CEST Update https://www.mdpi.com/1999-4923/14/7/1516/xml
article pdf uploaded. 21 July 2022 14:01 CEST Updated version of record https://www.mdpi.com/1999-4923/14/7/1516/pdf
article html file updated 21 July 2022 14:02 CEST Update https://www.mdpi.com/1999-4923/14/7/1516/html
Back to TopTop